{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:06:33Z","timestamp":1786115193705,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015051","name":"Women's Health Dexeus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmoop.2026.108281","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:47:24Z","timestamp":1783442844000},"page":"108281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular effects of ovarian stimulation for fertility preservation in breast cancer: a paired-biopsy analysis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0513-645X","authenticated-orcid":false,"given":"Y.","family":"Barral El Gaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bras\u00f3-Maristany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3838-7920","authenticated-orcid":false,"given":"A.","family":"Borr\u00e1s Cap\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-4062","authenticated-orcid":false,"given":"I.","family":"Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Altinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chic Ruche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-1712","authenticated-orcid":false,"given":"S.","family":"Ganau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gonz\u00e1lez-Farre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-5727","authenticated-orcid":false,"given":"M.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2377-540X","authenticated-orcid":false,"given":"A.","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-9565","authenticated-orcid":false,"given":"D.","family":"Manau Trull\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2026.108281_bib1","series-title":"GLOBOCAN 2020: Breast Cancer Incidence","year":"2020"},{"key":"10.1016\/j.esmoop.2026.108281_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0929","article-title":"Trends in parity and breast cancer incidence in US women younger than 40 years from 1935 to 2015","volume":"3","author":"Lima","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.esmoop.2026.108281_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2026.108281_bib4","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.esmoop.2026.108281_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.esmoop.2026.108281_bib6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108281_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103337","article-title":"Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis","volume":"47","author":"S\u00f6nmezer","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.esmoop.2026.108281_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/09513590.2014.1003293","article-title":"Attitudes on fertility issues in breast cancer patients: an Italian survey","volume":"31","author":"Biglia","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.esmoop.2026.108281_bib10","article-title":"Knowledge, practice, and attitudes of physicians in low- and middle-income countries on fertility and pregnancy-related issues in young women with breast cancer","volume":"8","author":"Khan","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/PPO.0000000000000596","article-title":"Mechanistic effects of estrogens on breast cancer","volume":"28","author":"Santen","year":"2022","journal-title":"Cancer J"},{"key":"10.1016\/j.esmoop.2026.108281_bib12","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2005.04.011","article-title":"Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.esmoop.2026.108281_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/deac035","article-title":"Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis","volume":"37","author":"Arecco","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.esmoop.2026.108281_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2024.10.014","article-title":"Long-term safety of controlled ovarian stimulation for fertility preservation before chemotherapy in patients with breast cancer","volume":"123","author":"Shapira","year":"2025","journal-title":"Fertil Steril"},{"key":"10.1016\/j.esmoop.2026.108281_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102228","article-title":"Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?","volume":"9","author":"Benvenuti","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2026.108281_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10549-011-1870-y","article-title":"Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation","volume":"132","author":"Chung","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2026.108281_bib19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib20","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\/CAP guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki-67 in breast cancer: updated recommendations from the International Ki-67 in breast cancer working group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"Pt 2","key":"10.1016\/j.esmoop.2026.108281_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2017.10.003","article-title":"Update on tumor-infiltrating lymphocytes in breast cancer","volume":"52","author":"Dieci","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.esmoop.2026.108281_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib24","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108281_bib25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"EBCTCG. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.108281_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fendo.2018.00781","article-title":"Estrogen signaling in ER\u03b1-negative breast cancer: ER\u03b2 and GPER","volume":"9","author":"Girgert","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.esmoop.2026.108281_bib27","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/cells9112358","article-title":"Estrogen actions in triple-negative breast cancer","volume":"9","author":"Treeck","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.esmoop.2026.108281_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijgo.12806","article-title":"Serum estradiol level on trigger day impacts clinical pregnancy rate in modified natural frozen embryo transfer cycles","volume":"145","author":"Ramezanali","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.esmoop.2026.108281_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","article-title":"Estrogens and breast cancer","volume":"36","author":"Kim","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib30","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.esmoop.2026.108281_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1998.606","article-title":"Epithelial proliferation and hormone receptor status in the normal postmenopausal breast and the effects of hormone replacement therapy","volume":"78","author":"Hargreaves","year":"1998","journal-title":"Br J Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.esmoop.2026.108281_bib32","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.esmoop.2026.108281_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(10)70008-5","article-title":"Breast cancer molecular profiling with single sample predictors: a retrospective analysis","volume":"11","author":"Weigelt","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13058-016-0724-2","article-title":"Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups","volume":"18","author":"Netanely","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108281_bib35","doi-asserted-by":"crossref","first-page":"951s","DOI":"10.1158\/1078-0432.951s.11.2","article-title":"IMPACT Trialists. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival","volume":"11","author":"Dowsett","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108281_bib36","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.2010.31.6950","article-title":"Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: ACOSOG Z1031","volume":"29","author":"Ellis","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib37","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S1470-2045(20)30458-7","article-title":"Long-term outcome and prognostic value of Ki-67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC)","volume":"21","author":"Smith","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108281_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13058-019-1195-z","article-title":"Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial","volume":"21","author":"Adamo","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108281_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2026.108281_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10549-023-06888-1","article-title":"Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay","volume":"199","author":"Hurson","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2026.108281_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer: a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:49:54Z","timestamp":1785977394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926022234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2059702926022234"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108281","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular effects of ovarian stimulation for fertility preservation in breast cancer: a paired-biopsy analysis","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108281"}}